The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Feb. 01, 2017
Applicants:

Daniel Baty, Marseilles, FR;

Patrick Chames, Marseilles, FR;

Martine Mansais, Marseilles, FR;

Brigitte Kerfelec, Marseilles, FR;

Caroline Rozan, Marseilles, FR;

Inventors:

Daniel Baty, Marseilles, FR;

Patrick Chames, Marseilles, FR;

Martine Mansais, Marseilles, FR;

Brigitte Kerfelec, Marseilles, FR;

Caroline Rozan, Marseilles, FR;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
C07K 16/468 (2013.01); C07K 16/283 (2013.01); C07K 16/3007 (2013.01); C07K 2317/22 (2013.01); C07K 2317/31 (2013.01); C07K 2317/35 (2013.01); C07K 2317/52 (2013.01); C07K 2317/522 (2013.01); C07K 2317/569 (2013.01); C07K 2317/64 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/00 (2013.01); C07K 2319/74 (2013.01);
Abstract

The present invention relates to antigen binding formats for use in therapeutic treatments or diagnostic assays. The present invention relates to an antigen-binding format consisting of: —a first fusion protein wherein the CH1 constant domain of an antibody is fused i) by its N-terminal end to the C-terminal end of a variable domain of an antibody and ii) by its C-terminal end to the N-terminal end of a variable domain of an antibody and, —a second fusion protein wherein the CL constant domain of an antibody is fused by its N-terminal end to the C-terminal end of a variable domain of an antibody.


Find Patent Forward Citations

Loading…